Institution profile

一般社団法人紀祐会 REVHAUT CLINIC

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2503001 +4

Location

Prefecture
Osaka
Address
大阪市西区新町1丁目3番16号 オーゾラビル2階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 日本医理工連携 特定認定再生医療等委員会
  • NPO法人抜苦ねっと認定再生医療等委員会
  • JSCSF再生医療等委員会
  • +1

Public score

57.3/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 256of 1736

Registered technologies
5
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 57.3
Public score →100

Registered technologies (5)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来幹細胞による治療Stem cells (all sources)Adipose-derived stem cellsClass II
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
がんの治療と予防を目的としたNK細胞を用いたアンチエイジング療法NK and immune cellsClass III
悪性腫瘍に対する自家樹状細胞ワクチン療法NK and immune cellsClass III
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)NK and immune cellsClass III

Certified committee for regenerative medicine

  • 日本医理工連携 特定認定再生医療等委員会
  • NPO法人抜苦ねっと認定再生医療等委員会
  • JSCSF再生医療等委員会
  • 一般社団法人 細胞免疫学研究会 認定再生医療等委員会

Public document number

  • 02E2503001
  • 02E2512033
  • 02E2512034
  • 01E2511005
  • 01E2511006
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
慢性疼痛に対する自己脂肪由来幹細胞による治療Class II日本医理工連携 特定認定再生医療等委員会02E2503001
悪性腫瘍に対する免疫細胞(NK細胞、γδT細胞、CD8陽性細胞、CD4陽性細胞を含む)治療(生物応答修飾剤活性化細胞障害性リンパ球療法:BAK療法)Class IIINPO法人抜苦ねっと認定再生医療等委員会02E2512033
悪性腫瘍に対する自家樹状細胞ワクチン療法Class IIINPO法人抜苦ねっと認定再生医療等委員会02E2512034
動脈硬化関連血管障害リスクの低減を目的とした自己脂肪組織由来幹細胞治療Class IIJSCSF再生医療等委員会01E2511005
がんの治療と予防を目的としたNK細胞を用いたアンチエイジング療法Class III一般社団法人 細胞免疫学研究会 認定再生医療等委員会01E2511006

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor